XML 36 R25.htm IDEA: XBRL DOCUMENT v3.23.2
STOCKHOLDERS’ EQUITY (Tables)
6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
Schedule of option activity
               
   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Contractual Life 
Outstanding at December 31, 2022   336,758    12.54      
Granted   28,000    14.56      
Exercised             
Forfeited   (10,260)   21.85      
Outstanding at June 30, 2023   354,498   $12.43     6.75 Years  
Assumptions for options granted
 
  Six months ended
  June 30, 2023
Expected volatility 91.6% - 94.5%
Expected term 6.5 - 7 Years
Risk-free interest rate 3.55% - 3.77%
Weighted-average FV $11.74
Schedule of restricted stock award activity
          
   Nonvested Shares   Weighted-Average Grant Date Fair Value 
Nonvested at December 31, 2022   17,865   $14.11 
Granted   18,375    11.40 
Vested   (17,928)   12.49 
Nonvested at June 30, 2023   18,312   $12.97 
Schedule of common stock warrant activity
          
   Number of Warrants   Weighted Average Exercise Price 
Outstanding at December 31, 2022   440,204    9.73 
Granted   200,000    17.00 
Exercised   (20,099)   6.30 
Outstanding at June 30, 2023   620,105   $9.75 
Exercisable at June 30, 2023   620,105   $9.75